Business Description
Grace Therapeutics Inc. is a Canadian pharmaceutical company focused on bringing new treatments to patients with rare and underserved diseases. Its most advanced program, GTX-104, is an intravenous therapy aimed at treating bleeding around the brain, while two other candidates target a rare neurological disorder and nerve pain following shingles. Founded in 2002 and based in Princeton, New Jersey, the company was previously known as Acasti Pharma Inc. before adopting its current name in October 2024.
